Free access
Issue
Vet. Res.
Volume 35, Number 2, March-April 2004
Page(s) 149 - 161
DOI http://dx.doi.org/10.1051/vetres:2004007
How to cite this article Vet. Res. (2004) 149-161
References of Vet. Res. 35 149-161
  1. Alarcon J.B., Waine G.W., McManus D.P., DNA vaccines: technology and application as anti-parasite and anti-microbial agents, Adv. Parasitol. 42 (1999) 343-410 [PubMed].
  2. Babiuk L., van Drunen Littel-van den Hurk S., Babiuk S., Immunization of animals: from DNA to the dinner plate, Vet. Immunol. Immunopathol. 72 (1999) 189-202 [PubMed].
  3. Babiuk L., Babiuk S., Loehr B., van Drunnen Littel-van den Hurk S., Nucleic acid vaccines: research tool or commercial reality, Vet. Immunol. Immunopathol. 76 (2000) 1-23 [PubMed].
  4. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., van Drunen Littel-van den Hurk S., Induction of immune responses by DNA vaccines in large animals, Vaccine 21 (2003) 649-658 [CrossRef] [PubMed].
  5. Baehr W., Zhang Y.X., Joseph T., Su H., Nano F.E., Everett K.D., Caldwell H.D., Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes, Proc. Natl. Acad. Sci. USA 85 (1988) 4000-4004 [PubMed].
  6. Barry M.A., Johnston S.A., Biological features of genetic immunization, Vaccine 15 (1997) 788-791 [CrossRef] [PubMed].
  7. Buendía A.J., Sánchez J., Del Rio L., Garcés B., Gallego M.C., Caro M.R., Bernabé A., Salinas J., Differences in the immune response against ruminant chlamydial strains in a murine model, Vet. Res. 30 (1999) 495-507 [PubMed].
  8. Buxton D., Potential danger to pregnant women of Chlamydia psittaci from sheep, Vet. Rec. 118 (1986) 510-511 [PubMed].
  9. Buzoni-Gatel D., Rodolakis A., Plommet M., T cell mediated and humoral immunity in a mouse Chlamydia psittaci systemic infection, Res. Vet. Sci. 43 (1987) 59-63 [PubMed].
  10. Campbell L.A., Kuo C.C., Grayston J.T., Structural and antigenic analysis of Chlamydia pneumoniae, Infect. Immun. 58 (1990) 93-97 [PubMed].
  11. Campbell L.A., Kuo C.C., Wang S.P., Grayston J.T., Serological response to Chlamydia pneumoniae infection, J. Clin. Microbiol. 28 (1990) 1261-1264 [PubMed].
  12. Christiansen G., Boesen T., Hjernø K., Daugaard L., Mygind P., Madsen A.S., Knudsen K., Falk E., Birkelund S., Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity, Am. Heart J. 138 (1999) S491-S495 [PubMed].
  13. Coulter L.J., Sinclair M.C., Livingstone M., Maley S.W., Buxton D., Longbottom D., Validation of DNA vaccine constructs for Chlamydophila abortus protection studies, Res. Vet. Sci. 72 Suppl. A (2002) 24.
  14. Danko I., Wolff J.A., Direct gene transfer into muscle, Vaccine 12 (1994) 1499-1502 [CrossRef] [PubMed].
  15. Davis H.L., Michel M.L., Mancini M., Schleef M., Whalen R.G., Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen, Vaccine 12 (1994) 1503-1509 [CrossRef] [PubMed].
  16. De Sa C., Souriau A., Bernard F., Salinas J., Rodolakis A., An oligomer of the major outer membrane protein of Chlamydia psittaci is recognized by monoclonal antibodies which protect mice from abortion, Infect. Immun. 63 (1995) 4912-4916 [PubMed].
  17. Donati M., Sambri V., Comanducci M., Di Leo K., Storni E., Giacani L., Ratti G., Cevenini R., DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice, Vaccine 21 (2003) 1089-1093 [CrossRef] [PubMed].
  18. Dong-Ji Z., Yang X., Shen C., Lu H., Murdin A., Brunham R.C., Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses, Infect. Immun. 68 (2000) 3074-3078 [CrossRef] [PubMed].
  19. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A., DNA vaccines, Annu. Rev. Immunol. 15 (1997) 617-648 [CrossRef] [PubMed].
  20. Dufour V., DNA vaccines: new applications for veterinary medicine, Vet. Sci. Tomorrow, Issue 2 [on line] (2001) http://www.vetscite.org/cgi-bin/pw.exe/issue2/000022/000022.htm [consulted 24 January 2003].
  21. Eissenberg L.G., Wyrick P.B., Davis C.H., Rumpp J.W., Chlamydia psittaci elementary body envelopes: ingestion and inhibition of phagolysosome fusion, Infect. Immun. 40 (1983) 741-751 [PubMed].
  22. Everett K.D.E., Chlamydia and Chlamydiales: more than meets the eye, Vet. Microbiol. 75 (2000) 109-126 [CrossRef] [PubMed].
  23. Everett K.D.E., Bush R.M., Andersen A.A., Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms, Int. J. Syst. Bacteriol. 49 (1999) 415-440 [PubMed].
  24. Ferreira G., Monteiro G., Prazeres D., Cabral J., Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications, Trends Biotechnol. 18 (2000) 380-388 [CrossRef] [PubMed].
  25. Grayston J.T., Infections caused by Chlamydia pneumoniae strain TWAR, Clin. Infect. Dis. 15 (1992) 757-761 [PubMed].
  26. Gurunathan S., Klinman D.M., Seder R.A., DNA vaccines: immunology, application, and optimization, Annu. Rev. Immunol. 18 (2000) 927-974 [CrossRef] [PubMed].
  27. Gurunathan S., Wu C., Freidag B., Seder R., DNA vaccines: a key for inducing long-term cellular immunity, Curr. Opin. Immunol. 12 (2000) 442-447 [CrossRef] [PubMed].
  28. Hasan U.A., Abai A.M., Harper D.R., Wren B.W., Morrow W.J., Nucleic acid immunization: concepts and techniques associated with third generation vaccines, J. Immunol. Methods 229 (1999) 1-22 [CrossRef] [PubMed].
  29. Héchard C., Grépinet O., Rodolakis A., Protection evaluation against Chlamydophila abortus challenge by DNA vaccination with a dnaK-encoding plasmid in pregnant and non-pregnant mice, Vet. Res. 33 (2002) 313-326 [EDP Sciences] [CrossRef] [PubMed].
  30. Héchard C., Grépinet O., Rodolakis A., Evaluation of protection against Chlamydophila abortus challenge after DNA immunization with the major outer-membrane protein-encoding gene in pregnant and non-pregnant mice, J. Med. Microbiol. 52 (2003) 35-40 [CrossRef] [PubMed].
  31. Héchard C., Grépinet O., Rodolakis A., Proteic boost enhances humoral response induced by DNA vaccination with the dnaK gene of Chlamydophila abortus but fails to protect pregnant mice against a virulence challenge, Vet. Res. 34 (2003) 119-125 [EDP Sciences] [CrossRef] [PubMed].
  32. Hess J., Schaible U., Raupach B., Kaufmann S.H., Exploiting the immune system: toward new vaccines against intracellular bacteria, Adv. Immunol. 75 (2000) 1-88 [PubMed].
  33. Igietseme J.U., Murdin A., Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes, Infect. Immun. 68 (2000) 6798-6806 [CrossRef] [PubMed].
  34. Igietseme J.U., Black C.M., Caldwell H.D., Chlamydia vaccines: strategies and status, BioDrugs 16 (2002) 19-35 [PubMed].
  35. Johnston S.A., Barry M.A., Genetic to genomic vaccination, Vaccine 15 (1997) 808-809 [CrossRef] [PubMed].
  36. Kalman S., Mitchell W., Marathe R., Lammel C., Fan J., Hyman R.W., Olinger L., Grimwood J., Davis R.W., Stephens R.S., Comparative genomes of Chlamydia pneumoniae and C. trachomatis, Nat. Genet. 21 (1999) 385-389 [CrossRef] [PubMed].
  37. Kaufman R.J., Overview of vector design for mammalian gene expression, Mol. Biotechnol. 16 (2000) 151-160 [PubMed].
  38. Kikuta L.C., Puolakkainen M., Kuo C.C., Campbell L.A., Isolation and sequence analysis of the Chlamydia pneumoniae GroE operon, Infect. Immun. 59 (1991) 4665-4669 [PubMed].
  39. Krieg A.M., Immune effects and mechanisms of action of CpG motifs, Vaccine 19 (2001) 618-622 [CrossRef].
  40. Leclercq S., Harms J.S., Oliveira S.C., Enhanced efficacy of DNA vaccines against an intracellular bacterial pathogen by genetic adjuvants, Curr. Pharm. Biotechnol. 4 (2003) 99-107 [PubMed].
  41. Lewis P.J., Babiuk L.A., DNA vaccines: a review, Adv. Virus Res. 54 (1999) 129-188 [PubMed].
  42. Liu M.A., DNA vaccines: a review, J. Intern. Med. 253 (2003) 402-410 [PubMed].
  43. Longbottom D., Chlamydial vaccine development, J. Med. Microbiol. 52 (2003) 537-540 [CrossRef] [PubMed].
  44. Longbottom D., Coulter L.J., Animal chlamydioses and zoonotic implications, J. Comp. Pathol. 128 (2003) 217-244 [CrossRef] [PubMed].
  45. Lowrie D.B., Silva C.L., Tascon R.E., DNA vaccines against tuberculosis, Immunol. Cell Biol. 75 (1997) 591-594 [PubMed].
  46. Lowrie D.B., Tascon R.E., Bonato V.L., Lima V.M., Faccioli L.H., Stavropoulos E., Colston M.J., Hewinson R.G., Moelling K., Silva C.L., Therapy of tuberculosis in mice by DNA vaccination, Nature 400 (1999) 269-271 [CrossRef] [PubMed].
  47. Maloy K.J., Erdmann I., Basch V., Sierro S., Kramps T.A., Zinkernagel R.M., Oehen S., Kündig T.M., Intralymphatic immunization enhances DNA vaccination, Proc. Natl. Acad. Sci. USA 98 (2001) 3299-3303 [CrossRef] [PubMed].
  48. Martin T., Parker S.E., Hedstrom R., Le T., Hoffman S.L., Norman J., Hobart P., Lew D., Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection, Hum. Gene Ther. 10 (1999) 759-768 [CrossRef] [PubMed].
  49. McCafferty M.C., Herring A.J., Andersen A.A., Jones G.E., Electrophoretic analysis of the major outer membrane protein of Chlamydia psittaci reveals multimers which are recognized by protective monoclonal antibodies, Infect. Immun. 63 (1995) 2387-2389 [PubMed].
  50. McShane H., Prime-boost immunization strategies for infectious diseases, Curr. Opin. Mol. Ther. 4 (2002) 23-27 [PubMed].
  51. Mor G., Plasmid DNA: a new era in vaccinology, Biochem. Pharmacol. 55 (1998) 1151-1153 [CrossRef] [PubMed].
  52. Mor G., Singla M., Steinberg A.D., Hoffman S.L., Okuda K., Klinman D.M., Do DNA vaccines induce autoimmune disease? Hum. Gene Ther. 8 (1997) 293-300 [PubMed].
  53. Mor G., Yamshchikov G., Sedegah M., Takeno M., Wang R., Houghten R.A., Hoffman S., Klinman D.M., Induction of neonatal tolerance by plasmid DNA vaccination of mice, J. Clin. Investig. 98 (1996) 2700-2705.
  54. Murdin A.D., Dunn P., Sodoyer R., Wang J., Caterini J., Brunham R.C., Aujame L., Oomen R., Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection, J. Infect. Dis. 181 Suppl. 3 (2000) S544-S551.
  55. Mygind P., Christiansen G., Persson K., Birkelund S., Analysis of the humoral immune response to Chlamydia outer membrane protein 2, Clin. Diagn. Lab. Immunol. 5 (1998) 313-318 [PubMed].
  56. Nichols R.L., Murray E.S., Nisson P.E., Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs, J. Infect. Dis. 138 (1978) 742-746 [PubMed].
  57. Nichols W.W., Ledwith B.J., Manam S.V., Troilo P.J., Potential DNA vaccine integration into host cell genome, Ann. N.Y. Acad. Sci. 772 (1995) 30-39.
  58. Oshop G.L., Elankumaran S., Heckert R.A., DNA vaccination in the avian, Vet. Immunol. Immunopathol. 89 (2002) 1-12 [PubMed].
  59. Pal S., Theodor I., Peterson E.M., de la Maza L.M., Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge, Vaccine 15 (1997) 575-582 [CrossRef] [PubMed].
  60. Pal S., Barnhart K.M., Wei Q., Abai A.M., Peterson E.M., de la Maza L.M., Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge, Vaccine 17 (1999) 459-465 [CrossRef] [PubMed].
  61. Peeling R., Maclean I.W., Brunham R.C., In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein, Infect. Immun. 46 (1984) 484-488 [PubMed].
  62. Penttilä T., Vuola J.M., Puurula V., Anttila M., Sarvas M., Rautonen N., Mäkelä P.H., Puolakkainen M., Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2), Vaccine 19 (2001) 1256-1265.
  63. Peterson E.M., Cheng X., Markoff B.A., Fielder T.J., de la Maza L.M., Functional and structural mapping of Chlamydia trachomatis species- specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies, Infect. Immun. 59 (1991) 4147-4153 [PubMed].
  64. Pisetsky D.S., The immunologic properties of DNA, J. Immunol. 156 (1996) 421-423 [PubMed].
  65. Read T.D., Myers G.S., Brunham R.C., Nelson W.C., Paulsen I.T., Heidelberg J., Holtzapple E., Khouri H., Federova N.B., Carty H.A., Umayam L.A., Haft D.H., Peterson J., Beanan M.J., White O., Salzberg S.L., Hsia R.C., McClarty G., Rank R.G., Bavoil P.M., Fraser C.M., Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae, Nucleic Acids Res. 31 (2003) 2134-2147 [CrossRef] [PubMed].
  66. Read T.D., Brunham R.C., Shen C., Gill S.R., Heidelberg J.F., White O., Hickey E.K., Peterson J., Utterback T., Berry K., Bass S., Linher K., Weidman J., Khouri H., Craven B., Bowman C., Dodson R., Gwinn M., Nelson W., DeBoy R., Kolonay J., McClarty G., Salzberg S.L., Eisen J., Fraser C.M., Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39, Nucleic Acids Res. 28 (2000) 1397-1406 [CrossRef] [PubMed].
  67. Rockey D.D., Lenart J., Stephens R.S., Genome sequencing and our understanding of Chlamydiae, Infect. Immun. 68 (2000) 5473-5479 [CrossRef] [PubMed].
  68. Rodolakis A., In vitro and in vivo properties of chemically induced temperature-sensitive mutants of Chlamydia psittaci var. ovis: screening in a murine model, Infect. Immun. 42 (1983) 525-530 [PubMed].
  69. Rodolakis A., Bernard F., Lantier F., Mouse models for evaluation of virulence of Chlamydia psittaci isolated from ruminants, Res. Vet. Sci. 46 (1989) 34-39 [PubMed].
  70. Saikku P., Leinonen M., Mattila K., Ekman M.-R., Nieminen M.S., Mäkelä P.H., Huttunen J.K., Valtonen V., Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction, Lancet 2 (1988) 983-986 [PubMed].
  71. Scheerlinck J.P.Y., Genetic adjuvants for DNA vaccines, Vaccine 19 (2001) 2647-2656 [CrossRef] [PubMed].
  72. Shirai M., Hirakawa H., Kimoto M., Tabuchi M., Kishi F., Ouchi K., Shiba T., Ishii K., Hattori M., Kuhara S., Nakazawa T., Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA, Nucleic Acids Res. 28 (2000) 2311-2314 [CrossRef] [PubMed].
  73. Srivastava I.K., Liu M.A., Gene vaccines, Ann. Intern. Med. 138 (2003) 550-559 [PubMed].
  74. Stagg A.J., Vaccines against Chlamydia: approaches and progress, Mol. Med. Today 4 (1998) 166-173 [CrossRef] [PubMed].
  75. Stagg A.J., Elsley W.A., Pickett M.A., Ward M.E., Knight S.C., Primary human T-cell responses to the major outer membrane protein of Chlamydia trachomatis, Immunology 79 (1993) 1-9 [PubMed].
  76. Stephens R.S., Chlamydial genomics and vaccine antigen discovery, J. Infect. Dis. 181 Suppl. 3 (2000) S521-S523.
  77. Stephens R.S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., Mitchell W., Olinger L., Tatusov R.L., Zhao Q., Koonin E.V., Davis R.W., Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis, Science 282 (1998) 754-759 [CrossRef].
  78. Storz J., Eugster A.K., Altera K.P., Olander H.J., Behavior of different bovine chlamydial agents in newborn calves, J. Comp. Pathol. 81 (1971) 299-307 [PubMed].
  79. Strugnell R.A., Drew D., Mercieca J., DiNatale S., Firez N., Dunstan S.J., Simmons C.P., Vadolas J., DNA vaccines for bacterial infections, Immunol. Cell Biol. 75 (1997) 364-369 [PubMed].
  80. Svanholm C., Bandholtz L., Lobell A., Wigzell H., Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion, J. Immunol. Methods 228 (1999) 121-130 [CrossRef] [PubMed].
  81. Svanholm C., Bandholtz L., Castaños-Velez E., Wigzell H., Rottenberg M.E., Protective DNA immunization against Chlamydia pneumoniae, Scand. J. Immunol. 51 (2000) 345-353 [CrossRef] [PubMed].
  82. Tang D., DeVit M., Johnston S., Genetic immunization is a simple method for eliciting an immune response, Nature 356 (1992) 152-154 [CrossRef] [PubMed].
  83. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., Lowrie D.B., Vaccination against tuberculosis by DNA injection, Nat. Med. 2 (1996) 888-892 [PubMed].
  84. Ulmer J.B., Tuberculosis DNA vaccines, Scand. J. Infect. Dis. 33 (2001) 246-248 [CrossRef] [PubMed].
  85. Ulmer J.B., An update on the state of the art of DNA vaccines, Curr. Opin. Drug. Discov. Devel. 4 (2001) 192-197 [PubMed].
  86. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A., Heterologous protection against influenza by injection of DNA encoding a viral protein, Science 259 (1993) 1745-1749.
  87. van Drunen Littel-van den Hurk S., Loehr B.I., Babiuk L.A., Immunization of livestock with DNA vaccines: current studies and future prospects, Vaccine 19 (2001) 2474-2479 [CrossRef] [PubMed].
  88. Vanrompay D., Ducatelle R., Haesebrouck F., Chlamydia psittaci infections: a review with emphasis on avian chlamydiosis, Vet. Microbiol. 45 (1995) 93-119 [CrossRef] [PubMed].
  89. Vanrompay D., Cox E., Volckaert G., Goddeeris B., Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein, Clin. Exp. Immunol. 118 (1999) 49-55 [CrossRef] [PubMed].
  90. Vanrompay D., Cox E., Vandenbussche F., Volckaert G., Goddeeris B., Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations, Vaccine 17 (1999) 2628-2635 [CrossRef] [PubMed].
  91. Vanrompay D., Cox E., Kaiser P., Lawson S., Van Loock M., Volckaert G., Goddeeris B., Protection of turkeys against Chlamydophila psittaci challenge by parenteral and mucosal inoculations and the effect of turkey interferon-$\gamma$ on genetic immunization, Immunology 103 (2001) 106-112 [CrossRef] [PubMed].
  92. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., Leung L., Otten G.R., Thudium K., Selby M.J., Ulmer J.B., Increased DNA vaccine delivery and immunogenicity by electroporation in vivo, J. Immunol. 164 (2000) 4635-4640 [PubMed].
  93. Wolf K., Fischer E., Mead D., Zhong G., Peeling R., Whitmire B., Caldwell H.D., Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants, Infect. Immun. 69 (2001) 3082-3091 [CrossRef] [PubMed].
  94. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L., Direct gene transfer into mouse muscle in vivo, Science 247 (1990) 1465-1468.
  95. Zhang D.-J., Yang X., Shen C., Brunham R.C., Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain, Immunology 96 (1999) 314-321 [CrossRef] [PubMed].
  96. Zhang D.-J., Yang X., Berry J., Shen C., McClarty G., Brunham R.C., DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection, J. Infect. Dis. 176 (1997) 1035-1040 [PubMed].